Immunocore
IMCR
IMCR
125 hedge funds and large institutions have $1.92B invested in Immunocore in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.38% more ownership
Funds ownership: 73.44% → 76.82% (+3.4%)
9% less capital invested
Capital invested by funds: $2.12B → $1.92B (-$198M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
125
Holding in Top 10
7
Calls
$12.8M
Puts
$151K
Top Buyers
| 1 | +$26.4M | |
| 2 | +$22.8M | |
| 3 | +$11.3M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$10.8M |
| 5 |
Millennium Management
New York
|
+$9.83M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$11.8M | |
| 3 | -$6.85M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$4.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.23M |